Analysis of risk factors for adverse drug events in critically ill patients*

Critical Care Medicine

Volumn 40, Issue 3, 2012, Pages 823-828

  Kane Gill, Sandra L ^a,b   Kirisci, Levent ^a   Verrico, Margaret M ^a,b   Rothschild, Jeffrey M ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

adverse drug event reporting system; critical care; intensive care unit; medication error; risk factor; safety

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT; ANXIOLYTIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; ELECTROLYTE; FENTANYL; GASTROINTESTINAL AGENT; HEPARIN; MORPHINE; PHENYTOIN; PIPERACILLIN; SEDATIVE AGENT;

ADVERSE DRUG REACTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DATA BASE; EMERGENCY PATIENT; FEMALE; HUMAN; INTENSIVE CARE UNIT; KIDNEY INJURY; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOCYTOPENIA;

CASE-CONTROL STUDIES; CRITICAL ILLNESS; DRUG TOXICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84857562169     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318236f473     Document Type: Article

References (34)

1. Kane-Gill SL, Kowiatek JG, Weber RJ: A comparison of voluntarily reported medication errors in intensive care and general care units. Qual Saf Health Care 2010;19:55-59
2. Cullen DJ, Sweitzer BJ, Bates DW, et al: Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units. Crit Care Med 1997;25:1289-1297
3. Leape LL, Cullen DJ, Clapp MD, et al: Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-270
4. Kane-Gill SL, Dasta JF, Schneider PJ, et al:. Monitoring abnormal laboratory values as antecedents to drug-induced injury. J Trauma 2005;59:1457-1462
5. Poon EG, Cina JL, Churchill W, et al: Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy. Ann Intern Med 2006;145:426-434
6. Stockwell DC, Kane-Gill SL: Developing a patient safety surveillance system to identify adverse events in the intensive care unit. Crit Care Med 2010;38(Suppl 6): S117-S125
7. Rothschild JM, Keohane CA, Thompson S, et al: Intelligent intravenous infusion pumps to improve medication administration safety. AMIA Annu Symp Proc 2003;992
8. Bates DW, Miller EB, Cullen DJ, et al: Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med 1999;159:2553-2560
9. Hajjar ER, Hanlon JT, Artz MB, et al: Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003;1:82-89
10. Ajayi FO, Sun H, Perry J: Adverse drug reactions: A review of relevant factors. J Clin Pharmacol 2000;40:1093-1101
11. Evans RS, Lloyd JF, Stoddard GJ, et al: Risk factors for adverse drug events: A 10-year analysis. Ann Pharmacother 2005;39:1161-1168
12. Camiré E, Moyen E, Stelfox HT: Medication errors in critical care: Risk factors, prevention and disclosure. CMAJ Can Med Assoc J 2009;180:936-943
13. Kane-Gill S, Rea RS, Verrico MM, et al: Adverse drug event rates for high-cost and high-use drugs in the intensive care unit. Am J Health Syst Pharm 2006;63:1876-1881
14. Jha AK, Kuperman GJ, Teich JM, et al: Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998;5:305-314
15. Kane-Gill SL, Bellamy CJ, Verrico MM, et al: Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU). Pharmacoepidemiol Drug Saf 2009;18:1185-1191
16. Verrico MM, Pankaskie MC, Brufsky JW: Identifying adverse drug-related events (ADEs): antidote and toxic drug level alerts. Int Pharma Abstracts 1999;36:2312
17. National Cancer Institute Common Toxicity Criteria. December 15, 2010. Common terminology criteria for adverse events v4.0 (CTCAE). Available at: http://ctep. info.nih.gov/reporting/ctc.html. Accessed June 6, 2011
18. Jones JK: Definition of events associated with drugs: regulatory perspectives. J Rheumatol Suppl 1988;17:14-19
19. Oderda GM, Said Q, Evans RS, et al: Opioidrelated adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother 2007;41:400-407
20. Dormann H, Muth-Selbach U, Krebs S, et al: Incidence and costs of adverse reactions during hospitalization. Drug Safe 2000;22:161-168
21. Evans RS, Pestotnik SL, Classen DC, et al: Preventing adverse drug events in hospitalized patients. Ann Pharmacother 1994;28:523-527
22. Kilbridge PM, Campbell UC, Cozart HB, et al: Automated surveillance for adverse drug events at a community hospital and an academic medical center. J Am Med Inform Assoc 2006;13:372-377
23. Kane-Gill SL, Van Den Bos J, Handler SM: Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database. Ann Pharmacother 2010;44:983-993
24. Kelly WN: Can the frequency and risks of fatal adverse drug events be determined? Pharmacotherapy 2001;21:521-527
25. Bellomo R, Ronco C, Kellum JA, et al: Acute renal failure-Definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-R212
26. Pugh RN: Pugh's grading in the classification of liver decompensation. Gut 1992;33:1583
27. Rothschild JM, Landrigan CP, Cronin JW, et al: The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 2005;33:1694-1700
28. Onder G, Petrovic M, Tangiisuran B, et al: Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med 2010;170:1142-1148
29. Cousins DH, Sabatier B, Begue D, et al: Medication errors in intravenous drug preparation and administration: A multicentre audit in the UK, Germany and France. Qual Saf Health Care 2005;14:190-195
30. Valentin A, Capuzzo M, Guidet B, et al: Errors in administration of parenteral drugs in intensive care units: multinational prospective study. BMJ 2009;338:b814
31. Nuckols TK, Paddock SM, Bower AG, et al: Costs of intravenous adverse drug events in academic and nonacademic intensive care units. Med Care 2008;46:17-24
32. Valentin A, Capuzzo M, Guidet B, et al: Patient safety in intensive care: Results from the multinational Sentinel Events Evaluation (SEE) study. Intensive Care Med 2006;32:1591-1598
33. Macedo AF, Alves C, Craveiro N, et al: Multiple drug expose as a risk factor for the seriousness of adverse drug reactions. J Nurs Manag 2011;19:395-399
34. Institute for Healthcare Improvement. IHI Global trigger tool for measuring adverse events. Available at: http://www.ihi.org/IHI/Topics/ PatientSafety/SafetyGeneral/Tools/IHIGlobalTriggerToolforMeasuringAEs.htm. Accessed June 20, 2011